This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2002 Mar 15;20(6):1709.

doi: 10.1200/JCO.2002.20.6.1709.

Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?

S B Tan, D Machin, Y B Cheung, Y F A Chung, B C Tai, D Machin

PMID: 11896125
DOI: 10.1200/JCO.2002.20.6.1709

Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?

S B Tan et al. J Clin Oncol. 2002.

. 2002 Mar 15;20(6):1709.

doi: 10.1200/JCO.2002.20.6.1709.

Authors

S B Tan, D Machin, Y B Cheung, Y F A Chung, B C Tai, D Machin

PMID: 11896125
DOI: 10.1200/JCO.2002.20.6.1709

No abstract available

PubMed Disclaimer

Similar articles

Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR, Hilson AJ. Novell JR, et al. J Nucl Med. 1994 Aug;35(8):1318-20. J Nucl Med. 1994. PMID: 8046486 No abstract available.
Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY, Lai EC, Leung TW, Yu SC. Lau WY, et al. Ann Surg. 2008 Jan;247(1):43-8. doi: 10.1097/SLA.0b013e3181571047. Ann Surg. 2008. PMID: 18156922 Clinical Trial.
The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
Brans B, De Winter F, Defreyne L, Troisi R, Vanlangenhove P, Van Vlierberghe H, Lambert B, Praet M, de Hemptinne B, Dierckx RA. Brans B, et al. Cancer Biother Radiopharm. 2001 Aug;16(4):333-8. doi: 10.1089/108497801753131417. Cancer Biother Radiopharm. 2001. PMID: 11603004
131-iodine Lipiodol therapy in hepatocellular carcinoma.
Raoul JL, Boucher E, Roland V, Garin E. Raoul JL, et al. Q J Nucl Med Mol Imaging. 2009 Jun;53(3):348-55. Q J Nucl Med Mol Imaging. 2009. PMID: 19521315 Review.
Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.
Bhattacharya S, Dusheiko GM. Bhattacharya S, et al. Princess Takamatsu Symp. 1995;25:253-64. Princess Takamatsu Symp. 1995. PMID: 8875631 Review.

See all similar articles

Cited by

Strategy for randomised clinical trials in rare cancers.
Tan SB, Dear KB, Bruzzi P, Machin D. Tan SB, et al. BMJ. 2003 Jul 5;327(7405):47-9. doi: 10.1136/bmj.327.7405.47. BMJ. 2003. PMID: 12842959 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information